Pradeep David, General Manager, South Asia, Universal Robots highlights how pharma industry is adopting robotics to improve efficiency and efficacy pharma industry too has begun adopting robotics
Automation in its broadest sense has expanded from its original industrial manufacturing base to laboratories and businesses. The application of robotics and automation has been successfully achieved in a wide range of industries dealing with well-defined processes and products like the manufacturing industry, FMCG, automotive industry, the healthcare industry, the pharmaceutical industry, to name a few.
Technological advancements have revolutionised automation to the current level of complexity and flexibility; even so, the pharma industry faces a few issues. As the commercial environment is getting harsher, the healthcare payers impose new-cost constraints on healthcare providers who scrutinise the value medicines offer, much more carefully. This leads to a sharp rise in the customer expectations for newer therapies, which are economically better than existing alternatives, while being medically superior.
The industry output has remained at a stable level for the past decade. Using the same discovering and developing processes, there’s little reason to think its productivity will suddenly soar. Lastly, the prevailing management culture, mental models and strategies on which the industry relies are traditional, even though they’ve been eclipsed by innovative ways of doing business, leaving a huge margin for human error.
Automation improves compliance and minimises deviations by connecting instruments to electronic systems, so users don’t have to manually enter data. Cloud- based software, with appropriate security protocols can be adopted to facilitate integration and automation. This reduces the paper work of the companies, making data manageable.
The other benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability, reproducibility, and in clean-rooms, removing the potential for human contamination.
Robots, as are being introduced into every industry, the pharma industry too has begun adopting robotics in production and distribution. A study by the Association for Packaging and Processing Technologies (PMMI) found that robots are expected to handle 34 per cent of primary pharma packaging operations in the US by 2018, compared with 21 per cent in 2013. An increase in the use of robots is seen in dispensing, sorting, kit assembly, and light machine-tending as well as in more traditional applications associated with packaging. The global use of robotics in the pharma sector has invariably increased in the past couple of years.
With the idea of higher production rate and the need for human interaction with machine automation, the Collaborative robots were first developed in 2008 by Universal Robots. Universal Robots are the leading manufacturers of advanced user-friendly and light industrial robotic arms from Denmark. Their latest technological advancement in collaborative robots or ‘Cobots’ was brought out in the international market with a peculiar intention which is in line with Industrial 4.0; which is also in sync with the automated revolution in the pharma industry. Robotic arms from Universal Robots are designed to meet the pharma industry’s specifications for accuracy, precision and hygiene. Robotics in the pharma industry is performing a wide range of tasks: from packaging of medical devices and implants as well as assisting in surgeries. The robot arms from Universal Robots can be used for mixing, counting, dispensing and inspection to deliver consistent results for business-critical products. They can also be used for sterile handling and assembly of the small, delicate parts that are used in prosthetics, implants and medical devices.
Three robotic arms from Universal Robots namely UR3, UR5 and UR10 can be incorporated into the processes so that engineers could easily adapt the software to the specific needs of the drugs and the required tasks. The easy programming, installation and collaborative nature of the industrial robot arms allow them to work side-by-side with the workforce for the production of efficient, high-quality medicines.
Automation has been an indispensable part of the Indian manufacturing industry for decades now and has seen remarkable improvements in the efficiency and productivity of the industry.
According to IBEF, the domestic Indian pharma industry was estimated to be $36 billion in 2016 growing at nearly 20 per cent and is expected to reach nearly $55 billion in 2020. It is evident that a lot of internal factors are responsible for the growing Indian pharma industry. There are more than 200 companies’ medicines for the largest population in the world which adds to the prevailing competition on the domestic front. The Indian pharma industry is a success story in developing countries because within a span of three decades, India has become one of the world’s largest manufacturers of medicines.
The past decade has seen a change in the mindset of most pharma companies and a digital wave has swept the $36 billion Indian pharma industry. The industry is now keen in adopting technology in every aspect of their operations.
Thus, the incorporation of collaborative robots will be a timely introduction to revolutionise the Indian pharma industry which will bring optimisation of processes, reduce waste, improve yield in production, with higher efficiency and precision. The functions that have already embraced automation will continue to prevail with incremental improvements from the normal cycle of technological innovation. Areas that are likely to witness quantum leaps will be in the integration between development work and manufacturing, efficiency and optimum utilisation of robotics in the industry.
Comments are closed.